The life sciences industry operates under uniquely stringent regulatory requirements where technology systems must not only ...
Drug manufacturers' use of AI has recently increased significantly, according to the FDA. Here's how the agency says the ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...
BioPharma Consulting Group today announced the launch of a new digital transformation advisory framework designed to ...
Successful implementation requires modern healthcare infrastructure, including reliable electricity, high-speed internet ...
This course offers a strategic edge by refining cloud system classification through CSA principles, preventing compliance pitfalls and inefficiencies. It empowers teams to enhance validation precision ...
Embrace Computer Software Assurance (CSA) for modern life-sciences by focusing on meaningful evidence rather than burdensome documentation. This approach enhances efficiency, aligns with FDA ...
This training unlocks opportunities for companies to modernize GxP validation by shifting to Computer Software Assurance, ensuring data integrity and compliance with FDA regulations, and addressing ...
In the 1999 sci-fi classic The Matrix, “plugging in” symbolized digital enslavement. In 2025, for a paraplegia patient in ...
The SNS records neural activity from 60 channels across four brain regions—an order-of-magnitude increase over commercially ...
After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback